Thursday, August 03, 2023
In response to the ongoing shortage of Intra-Abdominal Pressure (IAP) transducer kits, Sentinel Medical Technologies has taken action to ensure the continuity of uncompromised patient care. Their FDA-approved product, TraumaGuard, is now available as a reliable alternative to CR BARD or Centurion IAP kits.
IAP monitoring is crucial in patient care, particularly in operating rooms (OR) and intensive care units (ICU), as it helps medical teams assess the risk of developing Intra-Abdominal Hypertension (IAH) and Abdominal Compartment Syndrome (ACS). These conditions can have severe consequences if not promptly addressed, making the shortage of transducer kits a challenge for healthcare providers to deliver essential care effectively.
TraumaGuard offers a viable solution to this issue. It is an FDA-approved device that facilitates continuous and hands-free monitoring of IAP, Core Body Temperature, and bladder drainage for critical care patients across all departments. By allowing the device to remain in place for up to 30 days, TraumaGuard reduces the burden on clinical staff and streamlines workflow.
The technology of TraumaGuard prioritizes patient safety with its active detection of the advancement toward Abdominal Compartment Syndrome (ACS). The system sends proactive alerts to both bedside and nurses' stations while automatically recording and storing measurements in the existing Electronic Medical Record (EMR) database. This enables timely interventions that can prevent the escalation of adverse patient conditions.
TraumaGuard not only provides clinical benefits but also offers significant cost savings. Without requiring capital equipment and easily integrating with existing bedside monitors, it proves to be a cost-effective and equivalent replacement for current IAP devices. Overall, TraumaGuard ensures that patient care remains uncompromised, even amidst the challenges posed by the IAP transducer kit shortage.
Source: prnewswire.com
